Pathogenesis and treatment of the antiphospholipid antibody syndrome

Research output: Contribution to journalArticlepeer-review


Antiphospholipid antibody syndrome (APS) is one of the most important causes of thrombophilia, presenting most often as venous or arterial thrombosis, recurrent pregnancy loss, or thrombocytopenia. Both the lupus anticoagulant and anticardiolipin antibody are associated with APS. The mechanism of the prothrombotic state is not understood, but may involve beta- 2 glycoprotein I (a naturally occurring anticoagulant), platelet aggregation, the protein C pathway, or endothelial cell function. The current treatment recommendation, after a venous or arterial thrombosis, is high-intensity, long-term warfarin therapy.

Original languageEnglish (US)
Pages (from-to)151-177
Number of pages27
JournalMedical Clinics of North America
Issue number1
StatePublished - Jan 1 1997
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Pathogenesis and treatment of the antiphospholipid antibody syndrome'. Together they form a unique fingerprint.

Cite this